Genmab | Utile Per Azione

Prezzo Delle Azioni
1,881.00
Cambio Giornaliero
-0.50 -0.03%
Mensile
-12.35%
Annuale
26.24%
Q1 Previsione
1,860.10

Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07 2025
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08 2025
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12 2025
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06 2024
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08 2024




Eps Cambiamento Data
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Almirall EUR 0.1 0.06 2025-06
Amarin USD 0.08 0.11 2025-09
Amgen USD 5.29 0.35 2025-12
argenx SE USD 4.44 1.18 2025-09
AstraZeneca USD 2.12 0.26 2025-12
Bayer EUR 0.57 0.66 2025-09
BioMarin Pharmaceutical USD 0.12 1.32 2025-09
Demant DKK 6.1 0.5 2025-12
Exelixis USD 0.97 0.19 2025-12
Fresenius Medical Care EUR 1.1 0.19 2025-09
Galapagos EUR -0.41 0.16 2025-09
Genmab DKK 34.31 14.07 2025-06
GlaxoSmithKline GBP 0.26 0.29 2025-12
GN Store Nord DKK 2.51 2.01 2025-12
GRIFOLS EUR 0.21 0.02 2025-09
Hikma Pharmaceutical USD 0.54 0.06 2025-06
Insmed USD -1.75 0.05 2025-09
Lonza CHF 6.07 1.92 2025-06
Merck EUR 2.32 0.56 2025-09
Novartis USD 2.04 0.38 2025-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
UCB EUR 2.44 0.45 2025-06


Genmab Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.